dc.contributor.author
Bungert, Alexander D.
dc.contributor.author
Urbantat, Ruth M.
dc.contributor.author
Jelgersma, Claudius
dc.contributor.author
Bekele, Biniam M.
dc.contributor.author
Mueller, Susanne
dc.contributor.author
Mueller, Annett
dc.contributor.author
Felsenstein, Matthäus
dc.contributor.author
Dusatko, Silke
dc.contributor.author
Blank, Anne
dc.contributor.author
Ghori, Adnan
dc.contributor.author
Boehm‐Sturm, Philipp
dc.contributor.author
Koch, Stefan P.
dc.contributor.author
Vajkoczy, Peter
dc.contributor.author
Brandenburg, Susan
dc.date.accessioned
2025-03-28T15:51:34Z
dc.date.available
2025-03-28T15:51:34Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47082
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46799
dc.description.abstract
Aims
Glioblastomas are high-grade brain tumours that are characterised by the accumulation of brain-resident microglia and peripheral macrophages. Recruitment of these myeloid cells can be facilitated by CCR2/CCL2 signalling. Besides the well-known CCR2+ macrophages, we have identified microglia expressing CCR2 in glioma tissues. Thus, we investigated how Ccr2-deficiency of one of the myeloid cell populations affects the other population and tumour biology.
Methods
We generated four chimeric groups to analyse single and combined Ccr2-deficiency of microglia and macrophages. On day 21 after tumour cell implantation (GL261), we conducted flow cytometry, immunofluorescence and real-time polymerase chain reaction analyses. Tumour volume and metabolism were determined by magnetic resonance imaging and magnetic resonance spectroscopy. Moreover, in vitro studies were performed with primary microglia and bone marrow-derived macrophages.
Results
We demonstrated reduced infiltration of macrophages and microglia depending on the lack of Ccr2. However, the total number of myeloid cells remained constant except for the animals with dual Ccr2-knockout. Both microglia and macrophages with Ccr2-deficiency showed impaired expression of proinflammatory molecules and altered phagocytic activity. Despite the altered immunologic phenotype caused by Ccr2-deficiency, glioma progression and metabolism were hardly affected. Alterations were detected solely in apoptosis and proliferation of tumours from animals with specific Ccr2-deficient microglia, whereas vessel stability was increased in mice with Ccr2-knockout in both cell populations.
Conclusion
These results indicate that microglia and macrophages provide a homoeostatic balance within glioma tissue and compensate for the lack of the corresponding counterpart. Moreover, we identified that the CCR2/CCL2 axis is involved in the immunologic function of microglia and macrophages beyond its relevance for migration.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Ccr2(- -) transgenic mice
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Myeloid cell subpopulations compensate each other for Ccr2-deficiency in glioblastoma
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e12863
dcterms.bibliographicCitation.doi
10.1111/nan.12863
dcterms.bibliographicCitation.journaltitle
Neuropathology and Applied Neurobiology
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.volume
49
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36346010
dcterms.isPartOf.issn
0305-1846
dcterms.isPartOf.eissn
1365-2990